Categories
Pages
-

SmartMedCN

Adjusting the price management mode of low-price drugs in Hunan

December 16th, 2016 | by

Hunan Development and Reform Commission recently published an announcement concerning drug prices. The announcement clarifies related policies about drug prices in Hunan medical institutions. According to the announcement, since the publication date of the announcement, sales without added profit should be implemented basing on the actual purchase price, when public medical institutions sell drugs (including secondary vaccine, excluding traditional Chinese medicine decoction pieces). For the sale of traditional Chinese medicine decoction pieces in public medical institutions, the added profit should not exceed 30 % on the basis of the cost price with tax (the wholesale price). The added profit of non-public medical institutions and social retail pharmacies can be formulated by institutions and pharmacies themselves. Drug prices should be shown to the public. (Source: Chinese Medicine News)

湖南调整低价药品价格管理方式

来源:中国医药报 2016-12-08

核心提示:湖南省发改委日前下发《关于进一步明确药品价格有关问题的通知》,对湖南省医疗机构药品价格有关政策进行了明确。根据通知内容,自通知发布之日起,公立医疗机构销售药品(含二类疫苗,中药饮片除外),以实际购进价格为基础,实行零差率销售;公立医疗机构销售中药饮片,以含税出厂价格(批发价格)为基础,按顺加不超过30%的加价率制定销售价格。非公立医疗机构和社会零售药店药品加价率由医疗机构和药店自主制定,并向社会公示药品价格。



Leave a Reply